Dec. 14, 2023 5:30 am ET|WSJ Pro

Drugmakers and distributors pledged tens of billions of dollars to settle lawsuits accusing them of helping fuel the country’s opioid crisis. But much of the money may never be paid.

Opioid victims are finding that billions of settlement dollars have been snared in the morass of the nation’s bankruptcy system, where they face financial engineering by sophisticated investors and management teams, roadblocks from the federal government, and extensive legal wrangling and costs.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Exodus of ‘iconic’ American companies is taking psychic toll on Russians

Depending on the Russian, the sight of so many well-known American companies…

Philadelphia Orchestra returns to China 50 years after historic visit

BEIJING — The Philadelphia Orchestra returned to Beijing on Tuesday for a…

AT&T Adds Wireless Customers, Takes $25 Billion Charge on Landlines

Business Earnings Telecom plans to keep spending big on build-out of 5G…

Fed Chairman’s Approach to Regulation Has Drawn Some Criticism

President Biden’s looming decision about who should be the next Federal Reserve…